Research Progress on the Effects and Mechanisms of L-carnitine on Improving Metabolic Syndrome

被引:0
|
作者
Sun C. [1 ]
Zhang Y. [1 ]
Chen Q. [2 ]
Li J. [3 ]
Li T. [3 ]
Wei Y. [1 ]
Gao X. [1 ]
机构
[1] College of Life Sciences, Qingdao University, Qingdao
[2] College of Food Science and Engineering, Qingdao Agricultural University, Qingdao
[3] Anqiu Huatao Food Co., Ltd, Weifang
关键词
improvement effects; L-carnitine; mechanisms; metabolic syndrome; trimethylamine N-oxide;
D O I
10.13386/j.issn1002-0306.2022030263
中图分类号
学科分类号
摘要
Metabolic syndrome is a group of clinical syndromes, including obesity, dyslipidemia, hypertension, hyperuricemia, hyperglycemia and insulin resistance. These syndromes are critical risk factors for cardiovascular disease and diabetes. Recent studies indicate that L-carnitine exhibits potential improvement effects on metabolic syndrome. In the current study, the sources of L-carnitine for human and the effects and mechanisms of L-carnitine on the major components of metabolic syndrome, such as obesity and dyslipidemia, etc were summarized. The potential health risk of L-carnitine by serving as a dietary precursor for trimethylamine N-oxide was also discussed. This study provides theoretical basis and references for the treatment of metabolic syndrome and the rational dietary supplement and utilization of L-carnitine. © 2023, Editorial Department of Science and Technology of Food Science. All rights reserved.
引用
收藏
页码:475 / 484
页数:9
相关论文
共 97 条
  • [81] GU S J, XU G, WEI X, Et al., Clinical observation of serum uric acid concentration on L-carnitine in the treatment of chronic heart failure[J], Chinese Journal of Medical Guide, 17, 7, pp. 697-698, (2015)
  • [82] ZHANG J J, WU Z B, CAI Y J, Et al., L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: A randomized controlled study [J], Nutrition Journal, 13, 1, (2014)
  • [83] OLEK R A, SAMULAK J J, SAWICKA A K, Et al., Increased trimethylamine N-oxide is not associated with oxidative stress markers in healthy aged women[J], Oxidative Medicine and Cellular Longevity, (2019)
  • [84] CHEN X M, YOKOSE C, RAI S K, Et al., Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: The national health and nutrition examination survey, 2007-2016[J], Arthritis Rheumatol, 71, 6, pp. 991-999, (2019)
  • [85] ERALY S A, VALLON V, RIEG T, Et al., Multiple organic anion transporters contribute to net renal excretion of uric acid[J], Physiological Genomics, 33, 2, (2008)
  • [86] HABU Y, YANO I, TAKEUCHI A, Et al., Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: Roles of organic ion transporters, roat1, roat3 and roct2[J], Biochemical Pharmacology, 66, 6, (2003)
  • [87] SUBRAMANIAM S, FLETCHER C., Trimethylamine n-oxide: Breathe new life[J], British Journal of Pharmacology, 175, 8, pp. 1344-1353, (2018)
  • [88] HUSSEIN A R, GIULIA P, JUAN-CARLOS K D, Et al., The role of microbiota in cardiovascular risk: Focus on trimethylamine oxide[J], Current Problems in Cardiology, 44, 6, pp. 182-196, (2019)
  • [89] LUIGI B, GIUSEPPE A, GIOVANNA M, Et al., Trimethylamine n-oxide, mediterranean diet, and nutrition in healthy, normalweight adults: Also a matter of sex?[J], Nutrition (Burbank, Los Angeles County, Calif.), 62, pp. 7-17, (2019)
  • [90] CHEN S, HENDERSON A, PETRIELLO M C, Et al., Trimethylamine N-oxide binds and activates PERK to promote metabolic dysfunction[J], Cell Metabolism, 30, 6, pp. 1141-1151, (2019)